Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
813.00    5.00 (0.62%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.13b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

AGM Statement

9 May 2017 10:30

RNS Number : 5967E
Savills PLC
09 May 2017
 

9 May 2017

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following AGM statement.

 

During the year to date Savills has traded in line with our expectations and ahead of the corresponding period in 2016, both as reported and on a constant currency basis.

 

In the UK commercial markets, Savills has maintained a significant share of the Prime Central London investment and leasing markets, although market uncertainty continues to affect transactional volumes. Outside London, our transactional volumes and Professional and Development services have grown over the comparable period in 2016.

 

As expected, volumes in the UK Prime Residential market have been lower in the year to date compared with the very strong comparable period in advance of April 2016's increase in Stamp Duty. Our UK Rural business has performed better than anticipated. The period leading up to the UK General Election is expected to have a short term adverse impact on residential transaction activity over the next few weeks.

 

Savills Asia Pacific business has had a very strong start to the year. We have seen substantial underlying revenue and profit growth in the year to date, with Hong Kong, Australia and Japan all ahead of our expectations; in addition, our reported results continue to benefit from the effect of Sterling weakness.

 

In the US, Savills Studley has had a slower start to the year than initially anticipated with some occupier transaction deferrals. However, the pipeline of activity for the remainder of the year remains good. In addition we have continued to expand our footprint with acquisitions and significant recruitment in Southern California, Denver, Colorado and a Capital Markets team in New York.

 

In Continental Europe, to date we have traded in line with our expectations, with France, the Netherlands, Spain and Italy experiencing a particularly strong start to the year.

 

Globally, our Consultancy and Property Management businesses have delivered continued revenue growth with particular strengths in the UK and Asia.

 

Following a strong year in 2016, Savills Investment Management has grown revenue and profits as anticipated for the period to date as we near the end of the disposal of assets within the liquidating German Open Ended Funds under the SEB brand.

 

While we have started the year well, typically the first four months represent a disproportionately small element of the expected outturn for the full year. Against a political and economic backdrop which demonstrates greater levels of uncertainty than a few months ago, we continue to anticipate that our performance will remain in line with our expectations.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMLIFIAELIAIID
Date   Source Headline
24th Nov 20223:25 pmRNSDirector/PDMR Shareholding
14th Nov 20229:29 amRNSDirector/PDMR Shareholding
11th Oct 20224:21 pmRNSDirector/PDMR Shareholding
10th Oct 20224:36 pmRNSDirector/PDMR Shareholding
30th Sep 202210:00 amRNSDirector/PDMR Shareholding
13th Sep 20225:24 pmRNSDirector/PDMR Shareholding
1st Sep 202210:07 amRNSTotal Voting Rights
31st Aug 202210:00 amRNSDirector/PDMR Shareholding
16th Aug 20223:33 pmRNSBlock listing Interim Review
16th Aug 202211:12 amRNSDirector/PDMR Shareholding
11th Aug 20224:12 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSHalf-year Report
12th Jul 20223:34 pmRNSDirector/PDMR Shareholding
1st Jul 20223:56 pmRNSDirector/PDMR Shareholding
1st Jul 202210:00 amRNSTotal Voting Rights
20th Jun 20224:33 pmRNSHolding(s) in Company
17th Jun 20227:29 amRNSHolding(s) in Company
15th Jun 202212:00 pmRNSHolding(s) in Company
10th Jun 20223:46 pmRNSHolding(s) in Company
1st Jun 20222:22 pmRNSHolding(s) in Company
1st Jun 202210:00 amRNSTotal Voting Rights
31st May 20222:53 pmRNSHolding(s) in Company
27th May 202210:00 amRNSHolding(s) in Company
26th May 20223:56 pmRNSDirector/PDMR Shareholding
17th May 20225:17 pmRNSHolding(s) in Company
17th May 20225:12 pmRNSHolding(s) in Company
11th May 20225:44 pmRNSDirector/PDMR Shareholding
11th May 20222:22 pmRNSResult of AGM
11th May 20229:56 amRNSAGM Statement
3rd May 20227:00 amRNSTotal Voting Rights
27th Apr 20224:13 pmRNSDirectors Remuneration Report - Clarification
21st Apr 20224:57 pmRNSDirector/PDMR Shareholding
21st Apr 20224:44 pmRNSHolding(s) in Company
12th Apr 20222:23 pmRNSDirector/PDMR Shareholding
4th Apr 20224:28 pmRNSAnnual Report and AGM Notice
1st Apr 202210:00 amRNSTotal Voting Rights
14th Mar 202210:00 amRNSDirector/PDMR Shareholding
10th Mar 20227:00 amRNSFinal Results
3rd Mar 202211:00 amRNSTotal Voting Rights
15th Feb 202211:00 amRNSBlock listing Interim Review
14th Feb 202212:00 pmRNSDirector/PDMR Shareholding
1st Feb 202210:27 amRNSTotal Voting Rights
21st Jan 202210:00 amRNSBlock listing Interim Review
12th Jan 20227:00 amRNSYear End Trading Update
11th Jan 20223:04 pmRNSDirector/PDMR Shareholding
4th Jan 202211:19 amRNSTotal Voting Rights
31st Dec 202110:06 amRNSSavills IM & Samsung Life Investment Alliance
13th Dec 202112:38 pmRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSTotal Voting Rights
25th Nov 202112:07 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.